Glycemic ControlResistance training

Clinical evidence dossier

Resistance training

Fasting Plasma Glucose (FPG)

Evidence signal

Evidence signal

Strong

This is an authoritative evidence signal supplied by Clinical Reference. It is not a formal clinical grade, treatment recommendation, or pooled effect estimate.

Evidence snapshot

Authoritative support records
4
Supporting studies available for review
4
Randomized trials
4
Reported effects
7

Clinical conclusion

Resistance training shows a strong positive evidence signal for improving Fasting Plasma Glucose (FPG) across the studied comparisons.

Observed effects

Evidence composition

Non-randomized studies
0
Other designs
0
Unresolved designs
0
Magnitude-eligible effects
0

Consistency

Consistency classification

Consistent

Positive
4
No effect
0
Mixed
0
Negative
0

Population and applicability

Structured population data were available for 4 of 4 supporting studies. Diabetes type was heterogeneous: 3 studies with type 2 diabetes, 1 studies with type 1 diabetes. Age groups were heterogeneous: 1 studies with adult participants, 1 studies with youth participants.

This population information refers to the materialized supporting studies available for review. Omitted support records remain part of the authoritative support accounting and are available through the audit experience.

View reported population descriptions

These descriptions are reported across the supporting studies; they are not a single synthesized population.

  • Middle-aged patients diagnosed with type 2 diabetes.
  • Individuals looking to improve metabolic health through exercise.
  • Children diagnosed with Type 1 diabetes.
  • Participants engaging in regular physical activity.
  • Women aged 30-60 with type 2 diabetes.
  • Individuals seeking to manage diabetes through lifestyle changes.
  • Adults aged 18-65 with type 2 diabetes.
  • Individuals looking for effective exercise interventions to manage diabetes.

Limitations

  • 1 supporting study does not have a displayable topic-matched quantitative effect.
  • Evidence uses heterogeneous comparison contexts: active_comparator, usual_care.
  • 3 of 4 studies with duration data have follow-up of 12 weeks or less.

Supporting evidence

Inspect the authoritative studies and omitted support records for this dossier.

View supporting evidence